Coagulatory Defects in Type-1 and Type-2 Diabetes

被引：55
|
作者：
Sobczak, Amelie I. S. [1 ]
Stewart, Alan J. [1 ]
机构：
[1] Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2019年 / 20卷 / 24期
关键词：
atherosclerosis; endothelial dysfunction; magnesium; metal ions; microparticles; platelets; thrombosis; zinc; CHOLESTEROL EFFLUX CAPACITY; CORONARY-HEART-DISEASE; TISSUE FACTOR PATHWAY; ACTIVATABLE FIBRINOLYSIS INHIBITOR; ERYTHROCYTE-DERIVED MICROPARTICLES; DENSITY-LIPOPROTEIN FUNCTION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GLYCEMIC CONTROL; THROMBIN GENERATION;
D O I：
10.3390/ijms20246345
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of death for individuals with diabetes is cardiovascular diseases, in part since both types of diabetes lead to physiological changes that affect haemostasis. Those changes include altered concentrations of coagulatory proteins, hyper-activation of platelets, changes in metal ion homeostasis, alterations in lipid metabolism (leading to lipotoxicity in the heart and atherosclerosis), the presence of pro-coagulatory microparticles and endothelial dysfunction. In this review, we explore the different mechanisms by which diabetes leads to an increased risk of developing coagulatory disorders and how this differs between type-1 and type-2 diabetes.
引用
收藏
页数：27
相关论文
共 50 条
  • [21] EPIDEMIOLOGY OF TYPE-1 AND TYPE-2 DIABETES IN THE YOUNG-POPULATION OF MOSCOW
    LEBEDEV, N
    CURAEVA, T
    SERGEEV, A
    GUBANOV, N
    DEDOV, I
    DIABETOLOGIA, 1992, 35 : A130 - A130
  • [22] Glucose Measurement and Glycemic Control in Patients with Type-1 or Type-2 Diabetes
    Schlueter, Sandra
    Deiss, Dorothee
    Gehr, Bernhard
    Lange, Karin
    von Sengbusch, Simone
    Thomas, Andreas
    Ziegler, Ralph
    Freckmann, Guido
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 : S119 - S141
  • [23] DISCREPANCY BETWEEN ERYTHROCYTE VISCOSITY MEASUREMENTS IN TYPE-1 AND TYPE-2 DIABETES
    RILLAERTS, E
    DELEEUW, I
    VANGAAL, L
    CLINICAL HEMORHEOLOGY, 1987, 7 (03): : 465 - 465
  • [24] TYPE-1 AND TYPE-2 ALCOHOLICS - REPLY
    SCHUCKIT, MA
    IRWIN, M
    BRITISH JOURNAL OF ADDICTION, 1990, 85 (05): : 684 - 685
  • [25] TYPE-1 TYPE-2 - A RUSSIAN VIEW
    ALTSHULER, VB
    ADDICTION, 1994, 89 (09) : 1069 - 1069
  • [26] What is the type-1/type-2 distinction?
    Chater, N
    BEHAVIORAL AND BRAIN SCIENCES, 1997, 20 (01) : 68 - &
  • [27] Latent autoimmune (Type-1) diabetes mellitus in patients classified originally as Type-2 diabetes
    Martinka, E
    Straková, J
    Shawkatová, I
    Buc, M
    Mocán, M
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1211 - 1216
  • [28] ISLET PATHOLOGY AND THE PATHOGENESIS OF TYPE-1 AND TYPE-2 DIABETES-MELLITUS REVISITED
    KLOPPEL, G
    LOHR, M
    HABICH, K
    OBERHOLZER, M
    HEITZ, PU
    SURVEY AND SYNTHESIS OF PATHOLOGY RESEARCH, 1985, 4 (02): : 110 - 125
  • [29] Islet autoantibodies in type-1 or type-2 diabetes in four US racial groups
    Marker, JD
    Chopra, M
    Ten, S
    Su, K
    Zeidler, A
    Raskin, P
    Rappaport, R
    Schatz, D
    Vargas, A
    Malone, J
    Bode, B
    Krischer, J
    MacLaren, NK
    DIABETES, 2001, 50 : A262 - A262
  • [30] Bone Quality and Fracture-Healing in Type-1 and Type-2 Diabetes Mellitus
    Henderson, Shasta
    Ibe, Izuchukwu
    Cahill, Sean
    Chung, Yeon-Ho
    Lee, Francis Y.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2019, 101 (15): : 1399 - 1410
12345